{
  "query": "topical calcineurin corticosteroids inhibitors",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT05819463",
          "briefTitle": "Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 700,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07240389",
          "briefTitle": "Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Vulvar Lichen Sclerosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "FEMALE",
          "minimumAge": "30 Years",
          "healthyVolunteers": false,
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02079688",
          "briefTitle": "Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Mild to Moderate Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false,
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03720470",
          "briefTitle": "Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dermatitis", "Dermatitis, Atopic", "Eczema", "Skin Diseases", "Skin Diseases, Genetic", "Genetic Diseases, Inborn", "Skin Diseases, Eczematous", "Hypersensitivity", "Hypersensitivity, Immediate", "Immune System Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 838,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05650060",
          "briefTitle": "Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Plaque Psoriasis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 163,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04244006",
          "briefTitle": "A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Netherton Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03237533",
          "briefTitle": "Treatment Modalities of Oral Lichen Planus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Oral Lichen Planus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01202513",
          "briefTitle": "Topical Bimatoprost Solution 0.03%in Stable Vitiligo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2010-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Vitiligo", "Repigmentation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "10 Years",
          "healthyVolunteers": false,
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05139836",
          "briefTitle": "A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 634,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00119158",
          "briefTitle": "Combination Therapy for Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-10"
          },
          "completionDateStruct": {
            "date": "2005-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "2 Years",
          "healthyVolunteers": false,
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05250115",
          "briefTitle": "A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis, Atopic"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": true
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05492578",
          "briefTitle": "Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-01-22",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis Atopic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1663,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03823794",
          "briefTitle": "Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atopic Dermatitis Eczema", "Atopic Dermatitis", "Eczema"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 148166,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "0 Years",
          "healthyVolunteers": true
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05724199",
          "briefTitle": "A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 746,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false,
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02260986",
          "briefTitle": "Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2016-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 740,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03948334",
          "briefTitle": "A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04114097",
          "briefTitle": "The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atopic Dermatitis", "Atopic Eczema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false,
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06994520",
          "briefTitle": "Efficacy of Topical Cannabidiol for Eczema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Pruritus", "Eczema", "Nummular Eczema", "Atopic Dermatitis", "Prurigo Nodularis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "25 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05671263",
          "briefTitle": "Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lichen Sclerosus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": true
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03089229",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atopic Dermatitis", "Eczema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false,
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04183335",
          "briefTitle": "Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neurodermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false,
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03059693",
          "briefTitle": "Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis, Atopic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false,
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01246921",
          "briefTitle": "Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Patients With Active Non-segmental Vitiligo.", "Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%", "Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": true
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05136261",
          "briefTitle": "Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis Eczema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "3 Years",
          "healthyVolunteers": false,
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07234838",
          "briefTitle": "Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Psoriasis", "Condyloma Acuminata", "Biotherapies"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05056779",
          "briefTitle": "Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moderate-to-severe Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04202679",
          "briefTitle": "Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neurodermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false,
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03843437",
          "briefTitle": "Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-06-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "6 Months",
          "healthyVolunteers": false,
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05704205",
          "briefTitle": "The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Atopic Dermatitis Eczema", "Atopic Dermatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 316,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06983561",
          "briefTitle": "Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "healthyVolunteers": false,
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04250337",
          "briefTitle": "Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 228,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03921411",
          "briefTitle": "A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false,
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06224348",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis Atopic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 643,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "healthyVolunteers": false
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03863418",
          "briefTitle": "Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "6 Months",
          "healthyVolunteers": false,
          "maximumAge": "36 Months"
        }
      }
    ]
  }
}
